Bristol Myers trades higher after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter ...

Costco stock is lower Friday after the membership warehouse firm reported a top-line miss in its fiscal fourth quarter, but ...

Analyst Kelly Bania from BMO Capital reiterated a Buy rating on Costco (COST – Research Report) and increased the price target to $980.00 ...

These are the top stocks that gained the attention of retail traders and investors throughout the day: Alibaba Group Holding ...

Costco (COST – Research Report), the Consumer Cyclical sector company, was revisited by a Wall Street analyst today. Analyst Simeon ...

Shares jumped 6% in premarket trading after the Food and Drug Administration approved a treatment for [schizophrenia patients]( ...

U.S. stocks traded higher this morning, with the Dow Jones index rising more than 100 points on Friday. Following the market ...

Costco shares keep churning higher, but those gains have come predominantly from multiple expansion rather than earnings ...

Artificial intelligence technology is certainly among the most disruptive trends in the market for investors to consider.

Costco's merchandise costs rose to $69.588 billion for the quarter, up from $69.219 billion a year earlier. Also, selling, ...

S&P 500 and Dow Jones futures slip ahead of today’s inflation report. Investors brace for PCE data, which could signal the Fed’s next move on interest rates.